Yahoo
NasdaqCM - Nasdaq Real Time Price USD

HCW Biologics Inc. (HCWB)

1.6200 +0.0900 (+5.88%)
As of 11:24:43 AM EDT. Market Open.
Chart Range Bar
Loading chart for HCWB
  • Previous Close 1.5300
  • Open 1.5557
  • Bid 1.1900 x 200
  • Ask 1.9900 x 200
  • Day's Range 1.5557 - 1.6400
  • 52 Week Range 1.5000 - 27.5700
  • Volume 32,537
  • Avg. Volume 376,234
  • Market Cap (intraday) 3.623M
  • Beta (5Y Monthly) 2.42
  • PE Ratio (TTM) --
  • EPS (TTM) -19.8400
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 48.00

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases. The company also develops HCW9201, a fusion protein designed as a reagent to use in the production of natural killer (NK) cell-based therapies; HCW9206, a fusion protein designed as a reagent to use in the production of CAR-therapies for the treatment of infectious diseases; and HCW11-006, a multi-functional immune cell stimulator. It has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecule. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

www.hcwbiologics.com

35

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/9/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HCWB
72.19%
S&P 500 (^GSPC)
13.96%

1-Year Return

HCWB
94.05%
S&P 500 (^GSPC)
15.82%

3-Year Return

HCWB
99.66%
S&P 500 (^GSPC)
79.92%

5-Year Return

HCWB
99.76%
S&P 500 (^GSPC)
77.64%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 6.54M
Earnings 1.98M
Profit Margin 30.32%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-4M
-2M
0
2M
4M
6M
-20000.0%
-10000.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

48.00
48.00 Average
1.6200 Current
48.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/28/2026
Analyst Maxim Group
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 2 -> 5

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    3.05M

  • Enterprise Value

    8.87M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.19

  • Price/Book (mrq)

    0.41

  • Enterprise Value/Revenue

    1.32

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -83.05%

  • Return on Assets (ttm)

    -13.89%

  • Return on Equity (ttm)

    -151.36%

  • Revenue (ttm)

    6.72M

  • Net Income Avi to Common (ttm)

    -21.41M

  • Diluted EPS (ttm)

    -19.8400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    741.32k

  • Total Debt/Equity (mrq)

    88.34%

  • Levered Free Cash Flow (ttm)

    -11.66M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

1.6200 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Insider Picks for 12/06/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 12/05/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 12/04/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 11/30/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: